Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Jonsson Comprehensive Cancer Center
Children's Oncology Group
Dana-Farber Cancer Institute
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
Emory University
Children's Oncology Group
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
St. Jude Children's Research Hospital
Alliance for Clinical Trials in Oncology
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
University of Chicago
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)